Results 131 to 140 of about 3,351 (178)

Multi criterion decision making analysis of hematologic cancer drugs via topological indices and physicochemical properties. [PDF]

Sci Rep
Huang L, Hanif S, Siddiqui MK, Hanif MF, Hanif MF, Fiidow MA.   +5 more
europepmc   +1 more source

Advancements in research on the cardiovascular toxicity caused by TEC family kinases inhibitors. [PDF]

Front Pharmacol
Zhang Y, Fu H, Kang X, Qiu Z, Yan H, He Q, Yang B, Xu Z, Luo P.   +8 more
europepmc   +1 more source

Recall of ibrutinib and issues with therapeutic approval [PDF]

Haslam, Alyson, Kim, Myung Sun, Lipfert, Colton, Prasad, Vinay K   +3 more
core   +1 more source

Zanubrutinib as Upfront Treatment in de Novo B-Cell Prolymphocytic Leukemia: The Case of Two Elderly Patients. [PDF]

Mediterr J Hematol Infect Dis
Giorgi S, Leonardi G, Maccaferri M, Sbadili E, Caterina C, Fera G, Paolini A, Potenza L, Candoni A, Luppi M, Marasca R.   +10 more
europepmc   +1 more source

Zanubrutinib-induced petechial ecchymotic reaction in a previously irradiated area in a patient with chronic lymphocytic leukemia

JAAD Case Reports
Serena M. Vilasi, BS, Lydia A. Luu, MD, Mary M.B. Noland, MD   +2 more
doaj   +1 more source

Efficacy of BTK inhibitor combined with rituximab and lenalidomide in newly diagnosed diffuse large B-cell lymphoma: a single-center, retrospective study. [PDF]

Ann Hematol
Lv Y, Zhu Y, Yang C, Zhang X, Zhang X, Wei J, Ye X, Xu G, Mao L, Mai W, Yang M, Qian J, Tong H, Jin J, Yu W.   +14 more
europepmc   +1 more source

Individualized Treatment of IgM-Associated AL Amyloidosis [PDF]

Kroloff, Maxwell J., Lin, Tasha L.
core  

Effectiveness and Safety of Polatuzumab Vedotin Plus an Anti-CD20 Monoclonal Antibody (Rituximab or Obinutuzumab) and Zanubrutinib in Relapsed/Refractory Diffuse Large B-Cell Lymphoma. [PDF]

Cancer Med
Zhang Y, Ren Y, Zhuang J, Yuan L, Wang Z, Zhang X, Wang W, Cheng Z, Cheng L, Li J, Liu P.   +10 more
europepmc   +1 more source

Real-world cardiac events and outcomes in cBTKi-treated chronic lymphocytic leukemia patients. [PDF]

Future Oncol
Dingli D, De Nigris E, Leng S, Farooqui MZH, Yapici HO, Weimer I, Jiao W, Hyatt H, Zhang X, Lodaya K, Obeng-Kusi M.   +10 more
europepmc   +1 more source

A Confusing Case of Confusion: Bing-Neel Syndrome Treated With Zanubrutinib. [PDF]

EJHaem
Duell H, Clarke A, Bugg S.
europepmc   +1 more source